ROCHE: Actemra se relaciona con 15 muertes...

TOKYO, March 18 (Reuters) - Shares in Chugai Pharmaceutical Co (4519.T), the Japanese unit of Swiss drugmaker Roche Holding AG (ROG.VX), fell as much as 11 percent after Chugai reported 15 deaths among people that had used the Actemra arthritis drug.
Japan was the first country to approve Actemra for rheumatoid arthritis, viewed by Roche as a potential blockbuster. Actemra has won approval in Europe in January, but has yet to be approved in the United States.

Mas...